Cerebrolysin
- Generic Name
- Cerebrolysin
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 12656-61-0
- Unique Ingredient Identifier
- 37KZM6S21G
- Indication
用于脑血管疾病及脑动脉硬化、脑外伤或脑卒中后遗症、大脑发育不全、老年性痴呆以及记忆力减退者。
- Associated Conditions
- Alzheimer's Disease (AD), Cerebrovascular Diseases, Craniocerebral Injuries, Stroke
- Associated Therapies
- -
Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness
- First Posted Date
- 2018-03-29
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Ever Neuro Pharma GmbH
- Target Recruit Count
- 1851
- Registration Number
- NCT03480698
- Locations
- 🇦🇹
Krankenhaus der Barmherzigen Brüder Eisenstadt, Eisenstadt, Austria
🇦🇹CDK Salzburg, Universitätsklinik für Neurologie, Salzburg, Austria
🇦🇹Universitätsklinik Innsbruck, Innsbruck, Austria
Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke
- First Posted Date
- 2016-05-11
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT02768571
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Cerebrolysin REGistry Study in Stroke
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- Ever Neuro Pharma GmbH
- Target Recruit Count
- 1823
- Registration Number
- NCT02541227
- Locations
- 🇦🇹
AKH Linz, Linz, Austria
Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke
- Conditions
- Interventions
- First Posted Date
- 2014-05-29
- Last Posted Date
- 2020-08-24
- Lead Sponsor
- Shanghai 6th People's Hospital
- Target Recruit Count
- 84
- Registration Number
- NCT02149875
- Locations
- 🇨🇳
Shanghai Sixth People's Hospital, Shanghai, China
Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
- First Posted Date
- 2013-04-04
- Last Posted Date
- 2015-10-26
- Lead Sponsor
- Ever Neuro Pharma GmbH
- Registration Number
- NCT01822951
- Locations
- 🇦🇹
AKh Allgemeines Krankenhaus der Stadt Linz GmbH, Linz, Austria
The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery
- Conditions
- Interventions
- First Posted Date
- 2012-05-25
- Last Posted Date
- 2020-02-25
- Lead Sponsor
- Ever Neuro Pharma GmbH
- Target Recruit Count
- 46
- Registration Number
- NCT01606111
- Locations
- 🇭🇰
Prince of Wales Hospital, Hong Kong, Hong Kong
Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.
- Conditions
- Interventions
- First Posted Date
- 2011-07-07
- Last Posted Date
- 2011-12-23
- Lead Sponsor
- Clinical Institute of the Brain, Russia
- Target Recruit Count
- 30
- Registration Number
- NCT01388738
- Locations
- 🇷🇺
Clinical Institute of Brain, Ekaterinburg, Sverdlovsk region, Russian Federation
A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia
- Conditions
- Interventions
- First Posted Date
- 2009-07-28
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Ever Neuro Pharma GmbH
- Target Recruit Count
- 242
- Registration Number
- NCT00947531
- Locations
- 🇷🇺
Saratov Regional Psychiatric Hospital of Snt. Sofia, Saratov, Russian Federation
🇷🇺V. M. Bekhterev St. Petersburg Scientific Research Psychoneurological Institute, St. Petersburg, Russian Federation
🇷🇺Chita State Medical Academy/Veterans Hospital, Chita, Russian Federation
The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke
- First Posted Date
- 2009-03-24
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- Ever Neuro Pharma GmbH
- Target Recruit Count
- 1071
- Registration Number
- NCT00868283
- Locations
- 🇨🇳
Dalian third people Hospital, Dalian, China
🇨🇳FuJian Shengli Hospital, Fuzhou, China
🇨🇳The 4st Hospital affiliated Harbin Medical University, Harbin, China
Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2010-12-28
- Lead Sponsor
- Ever Neuro Pharma GmbH
- Target Recruit Count
- 119
- Registration Number
- NCT00840671
- Locations
- 🇭🇷
Clinical Hospital Split, Dept. of Neurology, Split, Croatia
🇦🇹Krankenhaus der Barmherzigen Brüder/Abteilung für Neurologie, Wien, Austria
🇨🇿University Hospital Plzen, Plzen, Czech Republic
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.